Laurus Labs Ltd
NSE:LAURUSLABS
Laurus Labs Ltd
NSE:LAURUSLABS
Price:
1 042.9
INR
0.39%
Market Closed
Market Cap:
₹563B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
IN |
|
Golden Energy and Resources Ltd
SGX:AUE
|
SG |
|
Prajay Engineers Syndicate Ltd
NSE:PRAENG
|
IN |
|
Xiangpiaopiao Food Co Ltd
SSE:603711
|
CN |
|
Voltas Ltd
NSE:VOLTAS
|
IN |
|
F
|
Fujian Tendering Co Ltd
SZSE:301136
|
CN |
|
Mueller Water Products Inc
NYSE:MWA
|
US |
|
TSKB Gayrimenkul Yatirim Ortakligi AS
IST:TSGYO.E
|
TR |
|
C
|
CSL Ltd
SWB:CSJ
|
AU |
|
Fuchun Technology Co Ltd
SZSE:300299
|
CN |
|
PJT Partners Inc
NYSE:PJT
|
US |
|
General Interface Solution (GIS) Holding Ltd
TWSE:6456
|
TW |
|
Tian Poh Resources Ltd
ASX:TPO
|
AU |
|
Fintech Scion Ltd
OTC:FINR
|
UK |
|
Xiaomi Corp
HKEX:81810
|
CN |
|
S
|
Shenzhen Huakong Seg Co Ltd
SZSE:000068
|
CN |
|
Iguatemi SA
BOVESPA:IGTI3
|
BR |
|
Vaishali Pharma Ltd
NSE:VAISHALI
|
IN |
|
Nagarro SE
XETRA:NA9
|
DE |
|
Gyldendal A/S
CSE:GYLD B
|
DK |
|
P
|
PW Medtech Group Ltd
HKEX:1358
|
CN |
|
Amorepacific Group
KRX:002790
|
KR |
|
L
|
Liuzhou Iron & Steel Co Ltd
SSE:601003
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
LAURUSLABS
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 1 042.9 INR,
Laurus Labs Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LAURUSLABS Multiples-Based Value
LOCKED
Multiples Across Competitors
LAURUSLABS Competitors Multiples
Laurus Labs Ltd Competitors
Laurus Labs Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
563B INR | 8.3 | 66.5 | 34 | 46.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
